7-N,2-dimethyl-7-N-[2-(1H-pyrrol-2-yl)ethyl]-3,6-dihydro-2H-1,4-diazepine-5,7-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6-dimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-[2-(furan-2-yl)ethylimino]-6,7-dimethyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;2-[2-(furan-2-yl)ethylimino]-7-methyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6,7-pentamethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6-tetramethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6,7-trimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-methyl-7-[2-(1H-pyrrol-2-yl)ethylimino]-1,2,3,6-tetrahydro-1,4-diazepin-5-amine

C102H164N40O6 — CID 158974077

About 7-N,2-dimethyl-7-N-[2-(1H-pyrrol-2-yl)ethyl]-3,6-dihydro-2H-1,4-diazepine-5,7-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6-dimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-[2-(furan-2-yl)ethylimino]-6,7-dimethyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;2-[2-(furan-2-yl)ethylimino]-7-methyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6,7-pentamethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6-tetramethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6,7-trimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-methyl-7-[2-(1H-pyrrol-2-yl)ethylimino]-1,2,3,6-tetrahydro-1,4-diazepin-5-amine

7-N,2-dimethyl-7-N-[2-(1H-pyrrol-2-yl)ethyl]-3,6-dihydro-2H-1,4-diazepine-5,7-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6-dimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-[2-(furan-2-yl)ethylimino]-6,7-dimethyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;2-[2-(furan-2-yl)ethylimino]-7-methyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6,7-pentamethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6-tetramethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6,7-trimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-methyl-7-[2-(1H-pyrrol-2-yl)ethylimino]-1,2,3,6-tetrahydro-1,4-diazepin-5-amine (PubChem CID 158974077) has the molecular formula C102H164N40O6 and a molecular weight of 2046.71 g/mol. Its IUPAC name is 7-N,2-dimethyl-7-N-[2-(1H-pyrrol-2-yl)ethyl]-3,6-dihydro-2H-1,4-diazepine-5,7-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6-dimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-[2-(furan-2-yl)ethylimino]-6,7-dimethyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;2-[2-(furan-2-yl)ethylimino]-7-methyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6,7-pentamethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6-tetramethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6,7-trimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-methyl-7-[2-(1H-pyrrol-2-yl)ethylimino]-1,2,3,6-tetrahydro-1,4-diazepin-5-amine.

Molecular Properties

• Compound Name: 7-N,2-dimethyl-7-N-[2-(1H-pyrrol-2-yl)ethyl]-3,6-dihydro-2H-1,4-diazepine-5,7-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6-dimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-[2-(furan-2-yl)ethylimino]-6,7-dimethyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;2-[2-(furan-2-yl)ethylimino]-7-methyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6,7-pentamethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6-tetramethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6,7-trimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-methyl-7-[2-(1H-pyrrol-2-yl)ethylimino]-1,2,3,6-tetrahydro-1,4-diazepin-5-amine
• PubChem CID: 158974077
• Molecular Formula: C102H164N40O6
• Molecular Weight: 2046.71 g/mol
• Exact Mass: 2045.38
• IUPAC Name: 7-N,2-dimethyl-7-N-[2-(1H-pyrrol-2-yl)ethyl]-3,6-dihydro-2H-1,4-diazepine-5,7-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6-dimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-[2-(furan-2-yl)ethylimino]-6,7-dimethyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;2-[2-(furan-2-yl)ethylimino]-7-methyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6,7-pentamethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6-tetramethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6,7-trimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-methyl-7-[2-(1H-pyrrol-2-yl)ethylimino]-1,2,3,6-tetrahydro-1,4-diazepin-5-amine
• SMILES: CC1CN=C(N(C)C)NC(N(C)CCc2ccco2)=N1.CC1CN=C(N)C/C(=N\CCc2ccc[nH]2)N1.CC1CN=C(N)CC(N(C)CCc2ccc[nH]2)=N1.CC1CN=C(N)N/C(=N/CCc2ccco2)N1.CC1CN=C(N)NC(N(C)CCc2ccco2)=N1.CC1N=C(N(C)C)NC(N(C)CCc2ccco2)=NC1C.CC1N=C(N)N/C(=N/CCc2ccco2)NC1C.CC1N=C(N)NC(N(C)CCc2ccco2)=NC1C
• InChI: InChI=1S/C15H25N5O.C14H23N5O.C13H21N5O.C13H21N5.2C12H19N5O.C12H19N5.C11H17N5O/c1-11-12(2)17-15(18-14(16-11)19(3)4)20(5)9-8-13-7-6-10-21-13;1-11-10-15-13(18(2)3)17-14(16-11)19(4)8-7-12-6-5-9-20-12;1-9-10(2)16-13(17-12(14)15-9)18(3)7-6-11-5-4-8-19-11;1-10-9-16-12(14)8-13(17-10)18(2)7-5-11-4-3-6-15-11;1-9-8-14-11(13)16-12(15-9)17(2)6-5-10-4-3-7-18-10;1-8-9(2)16-12(17-11(13)15-8)14-6-5-10-4-3-7-18-10;1-9-8-16-11(13)7-12(17-9)15-6-4-10-3-2-5-14-10;1-8-7-14-10(12)16-11(15-8)13-5-4-9-3-2-6-17-9/h6-7,10-12H,8-9H2,1-5H3,(H,16,17,18);5-6,9,11H,7-8,10H2,1-4H3,(H,15,16,17);4-5,8-10H,6-7H2,1-3H3,(H3,14,15,16,17);3-4,6,10,15H,5,7-9H2,1-2H3,(H2,14,16);3-4,7,9H,5-6,8H2,1-2H3,(H3,13,14,15,16);3-4,7-9H,5-6H2,1-2H3,(H4,13,14,15,16,17);2-3,5,9,14H,4,6-8H2,1H3,(H2,13,16)(H,15,17);2-3,6,8H,4-5,7H2,1H3,(H4,12,13,14,15,16)
• InChIKey: JODXHJHIXCHNGF-UHFFFAOYSA-N
• XLogP: 5.92
• TPSA: 595.25 Ų
• H-Bond Donors: 17
• H-Bond Acceptors: 39
• Rotatable Bonds: 24
• Heavy Atoms: 148
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2046.71
LogP ≤ 5	5.92
H-Bond Donors ≤ 5	17
H-Bond Acceptors ≤ 10	39

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'imine_1', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 7-N,2-dimethyl-7-N-[2-(1H-pyrrol-2-yl)ethyl]-3,6-dihydro-2H-1,4-diazepine-5,7-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6-dimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-[2-(furan-2-yl)ethylimino]-6,7-dimethyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;2-[2-(furan-2-yl)ethylimino]-7-methyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6,7-pentamethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6-tetramethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6,7-trimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-methyl-7-[2-(1H-pyrrol-2-yl)ethylimino]-1,2,3,6-tetrahydro-1,4-diazepin-5-amine?

The IUPAC name of 7-N,2-dimethyl-7-N-[2-(1H-pyrrol-2-yl)ethyl]-3,6-dihydro-2H-1,4-diazepine-5,7-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6-dimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-[2-(furan-2-yl)ethylimino]-6,7-dimethyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;2-[2-(furan-2-yl)ethylimino]-7-methyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6,7-pentamethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6-tetramethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6,7-trimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-methyl-7-[2-(1H-pyrrol-2-yl)ethylimino]-1,2,3,6-tetrahydro-1,4-diazepin-5-amine (CID 158974077) is 7-N,2-dimethyl-7-N-[2-(1H-pyrrol-2-yl)ethyl]-3,6-dihydro-2H-1,4-diazepine-5,7-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6-dimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-[2-(furan-2-yl)ethylimino]-6,7-dimethyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;2-[2-(furan-2-yl)ethylimino]-7-methyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6,7-pentamethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6-tetramethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6,7-trimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-methyl-7-[2-(1H-pyrrol-2-yl)ethylimino]-1,2,3,6-tetrahydro-1,4-diazepin-5-amine.

What is the SMILES notation for 7-N,2-dimethyl-7-N-[2-(1H-pyrrol-2-yl)ethyl]-3,6-dihydro-2H-1,4-diazepine-5,7-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6-dimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-[2-(furan-2-yl)ethylimino]-6,7-dimethyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;2-[2-(furan-2-yl)ethylimino]-7-methyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6,7-pentamethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6-tetramethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6,7-trimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-methyl-7-[2-(1H-pyrrol-2-yl)ethylimino]-1,2,3,6-tetrahydro-1,4-diazepin-5-amine?

The canonical SMILES for 7-N,2-dimethyl-7-N-[2-(1H-pyrrol-2-yl)ethyl]-3,6-dihydro-2H-1,4-diazepine-5,7-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6-dimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-[2-(furan-2-yl)ethylimino]-6,7-dimethyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;2-[2-(furan-2-yl)ethylimino]-7-methyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6,7-pentamethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6-tetramethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6,7-trimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-methyl-7-[2-(1H-pyrrol-2-yl)ethylimino]-1,2,3,6-tetrahydro-1,4-diazepin-5-amine is CC1CN=C(N(C)C)NC(N(C)CCc2ccco2)=N1.CC1CN=C(N)C/C(=N\CCc2ccc[nH]2)N1.CC1CN=C(N)CC(N(C)CCc2ccc[nH]2)=N1.CC1CN=C(N)N/C(=N/CCc2ccco2)N1.CC1CN=C(N)NC(N(C)CCc2ccco2)=N1.CC1N=C(N(C)C)NC(N(C)CCc2ccco2)=NC1C.CC1N=C(N)N/C(=N/CCc2ccco2)NC1C.CC1N=C(N)NC(N(C)CCc2ccco2)=NC1C.

What is the InChIKey of 7-N,2-dimethyl-7-N-[2-(1H-pyrrol-2-yl)ethyl]-3,6-dihydro-2H-1,4-diazepine-5,7-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6-dimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-[2-(furan-2-yl)ethylimino]-6,7-dimethyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;2-[2-(furan-2-yl)ethylimino]-7-methyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6,7-pentamethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6-tetramethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6,7-trimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-methyl-7-[2-(1H-pyrrol-2-yl)ethylimino]-1,2,3,6-tetrahydro-1,4-diazepin-5-amine?

The InChIKey is JODXHJHIXCHNGF-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H25N5O.C14H23N5O.C13H21N5O.C13H21N5.2C12H19N5O.C12H19N5.C11H17N5O/c1-11-12(2)17-15(18-14(16-11)19(3)4)20(5)9-8-13-7-6-10-21-13;1-11-10-15-13(18(2)3)17-14(16-11)19(4)8-7-12-6-5-9-20-12;1-9-10(2)16-13(17-12(14)15-9)18(3)7-6-11-5-4-8-19-11;1-10-9-16-12(14)8-13(17-10)18(2)7-5-11-4-3-6-15-11;1-9-8-14-11(13)16-12(15-9)17(2)6-5-10-4-3-7-18-10;1-8-9(2)16-12(17-11(13)15-8)14-6-5-10-4-3-7-18-10;1-9-8-16-11(13)7-12(17-9)15-6-4-10-3-2-5-14-10;1-8-7-14-10(12)16-11(15-8)13-5-4-9-3-2-6-17-9/h6-7,10-12H,8-9H2,1-5H3,(H,16,17,18);5-6,9,11H,7-8,10H2,1-4H3,(H,15,16,17);4-5,8-10H,6-7H2,1-3H3,(H3,14,15,16,17);3-4,6,10,15H,5,7-9H2,1-2H3,(H2,14,16);3-4,7,9H,5-6,8H2,1-2H3,(H3,13,14,15,16);3-4,7-9H,5-6H2,1-2H3,(H4,13,14,15,16,17);2-3,5,9,14H,4,6-8H2,1H3,(H2,13,16)(H,15,17);2-3,6,8H,4-5,7H2,1H3,(H4,12,13,14,15,16).

What are the key properties of 7-N,2-dimethyl-7-N-[2-(1H-pyrrol-2-yl)ethyl]-3,6-dihydro-2H-1,4-diazepine-5,7-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6-dimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-[2-(furan-2-yl)ethylimino]-6,7-dimethyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;2-[2-(furan-2-yl)ethylimino]-7-methyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6,7-pentamethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6-tetramethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6,7-trimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-methyl-7-[2-(1H-pyrrol-2-yl)ethylimino]-1,2,3,6-tetrahydro-1,4-diazepin-5-amine?

7-N,2-dimethyl-7-N-[2-(1H-pyrrol-2-yl)ethyl]-3,6-dihydro-2H-1,4-diazepine-5,7-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6-dimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-[2-(furan-2-yl)ethylimino]-6,7-dimethyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;2-[2-(furan-2-yl)ethylimino]-7-methyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6,7-pentamethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6-tetramethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6,7-trimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-methyl-7-[2-(1H-pyrrol-2-yl)ethylimino]-1,2,3,6-tetrahydro-1,4-diazepin-5-amine has a molecular weight of 2046.71 g/mol, XLogP of 5.92, 24 rotatable bonds, 17 hydrogen bond donors, and 39 hydrogen bond acceptors.

Where does this data come from?

All data for 7-N,2-dimethyl-7-N-[2-(1H-pyrrol-2-yl)ethyl]-3,6-dihydro-2H-1,4-diazepine-5,7-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6-dimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-[2-(furan-2-yl)ethylimino]-6,7-dimethyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;2-[2-(furan-2-yl)ethylimino]-7-methyl-1,3,6,7-tetrahydro-1,3,5-triazepin-4-amine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6,7-pentamethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-2-N,2-N,4-N,6-tetramethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;4-N-[2-(furan-2-yl)ethyl]-4-N,6,7-trimethyl-6,7-dihydro-3H-1,3,5-triazepine-2,4-diamine;2-methyl-7-[2-(1H-pyrrol-2-yl)ethylimino]-1,2,3,6-tetrahydro-1,4-diazepin-5-amine is sourced from PubChem (CID 158974077), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).